Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

BACKGROUND: Donor-specific anti-HLA antibodies (DSA) impact negatively on the outcome of intestinal grafts. Although the use of antibody-removal therapies (ART) is becoming more frequent in the last few years, issues regarding their timing and effectiveness remain under discussion. METHODS: In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasa-Lázaro, María, Ramos-Boluda, Esther, Mancebo, Esther, Castro-Panete, María José, González-Sacristán, Rocío, Serradilla, Javier, Andrés-Moreno, Ane Miren, Hernández-Oliveros, Francisco, Paz-Artal, Estela, Talayero, Paloma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932897/
https://www.ncbi.nlm.nih.gov/pubmed/36819192
http://dx.doi.org/10.3389/fped.2022.1074577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932897/
https://www.ncbi.nlm.nih.gov/pubmed/36819192
http://dx.doi.org/10.3389/fped.2022.1074577

Ejemplares similares